首页|升解通瘀汤联合八段锦治疗慢性心力衰竭气虚血瘀证的临床效果

升解通瘀汤联合八段锦治疗慢性心力衰竭气虚血瘀证的临床效果

扫码查看
目的:探讨慢性心力衰竭(CHF)气虚血瘀证患者采用升解通瘀汤联合八段锦治疗的临床效果。方法:选取2021 年 5 月—2023 年 5 月荆州市中医医院收治的 86 例CHF气虚血瘀证患者作为研究对象,以随机数表法将患者分为研究组(n=43)与对照组(n=43)。对照组给予美托洛尔治疗,研究组在对照组基础上给予升解通瘀汤联合八段锦治疗,比较两组临床疗效、中医症候积分、心功能、主要心血管不良事件(MACE)。结果:研究组总有效率为 95。35%,较对照组的79。07%更高,差异有统计学意义(P<0。05);治疗后,两组中医症候积分、左心室舒张末期内径(LVEDD)、左心室收缩末期内径(LVESD)较治疗前降低,6 分钟步行试验(6MWT)较治疗前增加,左心室射血分数(LVEF)较治疗前提高,且研究组优于对照组,差异有统计学意义(P<0。05);研究组MACE发生率较对照组更低,差异有统计学意义(P<0。05)。结论:CHF气虚血瘀证患者采用升解通瘀汤联合八段锦治疗,能提高临床疗效,降低中医症候积分,促进心功能改善,降低MACE发生率。
Clinical Effect of Shengjie Tongyu Decoction Combined with Baduanjin in the Treatment of Chronic Heart Failure with Qi Deficiency and Blood Stasis Syndrome
Objective:To explore the clinical effect of Shengjie Tongyu Decoction combined with Baduanjin in the treatment of patients with chronic heart failure(CHF)with Qi deficiency and blood stasis syndrome.Method:A total of 86 patients with CHF with Qi deficiency and blood stasis syndrome who admitted to Jingzhou Hospital of Traditional Chinese Medicine from May 2021 to May 2023 were selected as the research objects,the patients were divided into the study group(n=43)and control group(n=43)by random number table method.The control group was treated with Metoprolol,and the study group was treated with Shengjie Tongyu Decoction combined with Baduanjin on the basis of the control group.The clinical efficacy,traditional Chinese medicine symptom score,cardiac function and major adverse cardiovascular events(MACE)were compared between two groups.Result:The total effective rate of the study group was 95.35%,which was higher than 79.07%of the control group,and the difference was statistically significant(P<0.05);after treatment,the scores of traditional Chinese medicine symptoms,left ventricular end-diastolic diameter(LVEDD)and left ventricular end-systolic diameter(LVESD)in the two groups were lower than those before treatment,the 6-minute walking test(6MWT)were higher than those before treatment,and the left ventricular ejection fraction(LVEF)were higher than those before treatment,those in the study group were better than those in the control group,and the differences were statistically significant(P<0.05);the incidence of MACE in the study group was lower than that in the control group,the difference was statistically significant(P<0.05).Conclusion:Shengjie Tongyu Decoction combined with Baduanjin in the treatment of chronic heart failure(CHF)with Qi deficiency and blood stasis syndrome can improve clinical efficacy,reduce traditional Chinese medicine syndrome scores,improve heart function,and reduce the incidence of MACE.

Shengjie Tongyu DecoctionBaduanjinChronic heart failureQi deficiency and blood stasis syndromeClinical effect

彭丹

展开 >

荆州市中医医院 湖北 荆州 434000

升解通瘀汤 八段锦 慢性心力衰竭 气虚血瘀证 临床效果

2024

中外医学研究
中国医院管理杂志社

中外医学研究

影响因子:1.149
ISSN:1674-6805
年,卷(期):2024.22(35)